Anthony T Reder Selected Research

Estriol (Epiestriol)

1/2016

Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony T Reder Research Topics

Disease

33	Multiple Sclerosis 01/2022 - 03/2002
11	Relapsing-Remitting Multiple Sclerosis 01/2022 - 04/2004
6	Infections 01/2021 - 06/2014
3	Injection Site Reaction 01/2021 - 05/2014
3	Disease Progression 01/2021 - 09/2013
3	Neoplasms (Cancer) 01/2021 - 06/2014
3	Bradycardia 09/2014 - 02/2011
3	Macular Edema 07/2013 - 02/2011
2	COVID-19 01/2021 - 01/2021
2	Atrophy 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 05/2008
2	Herpes Zoster 01/2015 - 06/2014
2	Atrioventricular Block 09/2014 - 06/2014
2	Demyelinating Diseases (Demyelinating Disease) 12/2011 - 08/2002
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Thymoma (Thymic Carcinoma) 01/2021
1	Thymus Neoplasms (Thymus Neoplasm) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Temporal Lobe Epilepsy 01/2018
1	Epilepsy (Aura) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Latent Infection 09/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2016
1	Menstruation Disturbances 01/2016
1	Hypertension (High Blood Pressure) 06/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 06/2014
1	Lymphopenia (Lymphocytopenia) 06/2014
1	Autoimmune Diseases (Autoimmune Disease) 09/2013
1	Uveitis 07/2013
1	Neuromyelitis Optica (Devic's Disease) 02/2012
1	Chronic Disease (Chronic Diseases) 01/2011
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2009
1	Alzheimer Disease (Alzheimer's Disease) 05/2004
1	Central Nervous System Diseases (CNS Diseases) 05/2004
1	Brain Diseases (Brain Disorder) 08/2002

Drug/Important Bio-Agent (IBA)

10	Fingolimod Hydrochloride (FTY720)FDA Link 11/2016 - 02/2011
9	InterferonsIBA 01/2021 - 08/2002
7	Interferon-betaIBA 10/2012 - 08/2002
4	Glatiramer Acetate (Copaxone)FDA Link 06/2021 - 01/2010
4	Neutralizing AntibodiesIBA 01/2021 - 04/2004
3	Interferon beta-1a FDA Link 06/2021 - 01/2021
3	Interferon beta-1b (Betaseron)FDA Link 01/2019 - 04/2004
3	AntibodiesIBA 01/2018 - 06/2004
3	Interferon Type IIBA 08/2014 - 02/2012
2	peginterferon beta-1aIBA 06/2021 - 01/2021
2	Natalizumab (Tysabri)FDA Link 01/2021 - 01/2018
2	GadoliniumIBA 01/2021 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 09/2013 - 10/2010
2	RNA (Ribonucleic Acid)IBA 12/2011 - 05/2008
1	ocrelizumabIBA 01/2022
1	Pharmaceutical PreparationsIBA 06/2021
1	teriflunomideIBA 06/2021
1	diroximel fumarateIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Dimethyl FumarateIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 11/2019
1	Vitamin D FDA LinkGeneric 06/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018
1	Carboxy-LyasesIBA 01/2018
1	AcidsIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	SteroidsIBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	Hormones (Hormone)IBA 01/2016
1	Estriol (Epiestriol)IBA 01/2016
1	Alanine Transaminase (SGPT)IBA 06/2014
1	Transaminases (Aminotransferases)IBA 05/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2012
1	Immunomodulating AgentsIBA 07/2010
1	Immunoglobulins (Immunoglobulin)IBA 01/2010
1	GTP-Binding Proteins (G-Protein)IBA 01/2010
1	4-Aminopyridine (4 Aminopyridine)FDA Link 03/2009
1	Myelin-Oligodendrocyte GlycoproteinIBA 06/2004
1	Apolipoproteins E (ApoE)IBA 05/2004
1	ApolipoproteinsIBA 05/2004
1	CytokinesIBA 08/2002
1	Interleukin-10 (Interleukin 10)IBA 03/2002

Therapy/Procedure

16	Therapeutics 01/2022 - 08/2002
2	Injections 04/2016 - 01/2016
1	Aftercare (After-Treatment) 01/2021
1	Plasma Exchange 01/2018
1	Duration of Therapy 09/2016